- Home
- CVRX vs JRS Comparison
CVRX vs JRS Comparison
Compare CVRX & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- JRS
- Stock Information
- Founded
- CVRX 2000
- JRS 2001
- Country
- CVRX United States
- JRS United States
- Employees
- CVRX N/A
- JRS N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- JRS Finance/Investors Services
- Sector
- CVRX Health Care
- JRS Finance
- Exchange
- CVRX Nasdaq
- JRS Nasdaq
- Market Cap
- CVRX 203.9M
- JRS 231.7M
- IPO Year
- CVRX 2021
- JRS N/A
- Fundamental
- Price
- CVRX $9.48
- JRS $7.95
- Analyst Decision
- CVRX Buy
- JRS
- Analyst Count
- CVRX 7
- JRS 0
- Target Price
- CVRX $14.00
- JRS N/A
- AVG Volume (30 Days)
- CVRX 198.0K
- JRS 86.6K
- Earning Date
- CVRX 11-05-2025
- JRS 01-01-0001
- Dividend Yield
- CVRX N/A
- JRS 8.87%
- EPS Growth
- CVRX N/A
- JRS N/A
- EPS
- CVRX N/A
- JRS N/A
- Revenue
- CVRX $54,652,000.00
- JRS N/A
- Revenue This Year
- CVRX $11.32
- JRS N/A
- Revenue Next Year
- CVRX $18.58
- JRS N/A
- P/E Ratio
- CVRX N/A
- JRS N/A
- Revenue Growth
- CVRX 23.11
- JRS N/A
- 52 Week Low
- CVRX $4.30
- JRS $5.95
- 52 Week High
- CVRX $18.55
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- CVRX 60.99
- JRS 42.09
- Support Level
- CVRX $9.72
- JRS $7.88
- Resistance Level
- CVRX $11.30
- JRS $8.02
- Average True Range (ATR)
- CVRX 0.51
- JRS 0.09
- MACD
- CVRX -0.10
- JRS -0.02
- Stochastic Oscillator
- CVRX 40.57
- JRS 21.21
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.